Pharmagreen Biotech Liabilities 2025

Pharmagreen Biotech Aktienanalyse

What does Pharmagreen Biotech do?

Pharmagreen Biotech Inc is a Canadian company specializing in the production of cannabis plants. The company was founded in 2009. Initially, the company focused primarily on research in the field of plant biotechnology. It worked on developing plants with higher cold resistance for cultivation in colder regions. Research in breeding plants with higher nutritional value was also part of their focus. In 2017, the company recognized the incredible potential of the cannabis industry and decided to apply its expertise in this field. Pharmagreen Biotech Inc began large-scale production of cannabis plants, working closely with other industry leaders to optimize production and create the best possible conditions. Pharmagreen Biotech Inc places great importance on sustainability and environmental awareness. All production methods are designed with ecological sustainability in mind. The plants are grown in environmentally-friendly greenhouses and all waste is recycled and reused. The business model of Pharmagreen Biotech Inc is tailored to the needs of its customers. The company produces cannabis plants for the medical and recreational sectors. It offers various types of plants to meet the needs of customers, including plants for home cultivation to cater to the growing market for self-grown cannabis plants. Products offered by Pharmagreen Biotech Inc also include seeds, fertilizers, and specialized cultivation kits tailored to the needs of cannabis plants. The company works closely with laboratories and research institutions to maximize and optimize the quality and potency of its products. The company recently developed a new technology called "Speed Breeding," which allows for the rapid breeding of cannabis plants. This enables Pharmagreen Biotech Inc to serve an even larger portion of the market and provide faster availability of products for customers. Pharmagreen Biotech Inc is divided into various divisions, including medical cannabis production, recreational cannabis, plant products, and seed production. Each division is led by a specialized team focused on the needs and requirements of customers in that area. Overall, Pharmagreen Biotech Inc is an innovative and sustainable company focused on the needs of its customers. Its wide range of products and ongoing research and development make it an important player in the rapidly growing cannabis industry. Pharmagreen Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Pharmagreen Biotech's Liabilities

Pharmagreen Biotech's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Pharmagreen Biotech's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Pharmagreen Biotech's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Pharmagreen Biotech's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Pharmagreen Biotech’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Pharmagreen Biotech stock

What is the level of liabilities of Pharmagreen Biotech this year?

Pharmagreen Biotech has a debt balance of 3.19 M USD this year.

What were the liabilities of Pharmagreen Biotech compared to the previous year?

The liabilities of Pharmagreen Biotech have increased by 41.18% increased compared to the previous year.

What are the consequences of high debt for investors of Pharmagreen Biotech?

High liabilities can pose a risk for investors of Pharmagreen Biotech, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Pharmagreen Biotech?

Low liabilities mean that Pharmagreen Biotech has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Pharmagreen Biotech affect the company?

An increase in liabilities of Pharmagreen Biotech can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Pharmagreen Biotech affect the company?

A decrease in the liabilities of Pharmagreen Biotech can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Pharmagreen Biotech?

Some factors that can influence the liabilities of Pharmagreen Biotech include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Pharmagreen Biotech so important for investors?

The liabilities of Pharmagreen Biotech are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Pharmagreen Biotech take to modify the liabilities?

To change its liabilities, Pharmagreen Biotech can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Pharmagreen Biotech pay?

Over the past 12 months, Pharmagreen Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pharmagreen Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Pharmagreen Biotech?

The current dividend yield of Pharmagreen Biotech is .

When does Pharmagreen Biotech pay dividends?

Pharmagreen Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Pharmagreen Biotech?

Pharmagreen Biotech paid dividends every year for the past 0 years.

What is the dividend of Pharmagreen Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Pharmagreen Biotech located?

Pharmagreen Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pharmagreen Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pharmagreen Biotech from 7/13/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/13/2025.

When did Pharmagreen Biotech pay the last dividend?

The last dividend was paid out on 7/13/2025.

What was the dividend of Pharmagreen Biotech in the year 2024?

In the year 2024, Pharmagreen Biotech distributed 0 USD as dividends.

In which currency does Pharmagreen Biotech pay out the dividend?

The dividends of Pharmagreen Biotech are distributed in USD.